Recent Posts
- Hikma v. Vanda: Oral Argument Recap
- Teva v. Lilly should not be read as creating a new 112 rule for method of use claims
- Should ANDA filers be using the PTAB to mount early challenges to OB patents?
- Switching to WordPress
- Judge Hughes concurrence highlights post grant review appeal standing issue for pharma cases
Category: Claim Preclusion
-
Continuing on the subject of defendants challenging multiple related patents, I listened to oral argument recently in a case involving an allegation of collateral estoppel from IPR proceedings on district court litigation of related claims that raised some interesting arguments. (Kroy IP Holdings, LLC v. Groupon, Inc., Case No. 23-1359). In that case, the district…
